Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for receptor protein- tyrosine kinases
Most Correlated Studies
- Melanocytes with inducible oncogenic receptor Xmrk stimulated with EGF
- Human umbilical vein endothelial cells (HUVECs) adhering to soluble VEGFR1 or fibronectin
- Drug target sets for approved compounds
- Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
- Broad Connectivity Map (CMAP 2.0) compound database
Most Relevant Literature
- Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelia…
- Lymphangiogenesis is a feature of acute GVHD, and VEGFR-3 inhibition protects against experimental G…
- MMP14 Regulates VEGFR3 Expression on Corneal Epithelial Cells.
- VEGFR3 and CD31 as prognostic factors in renal cell cancer.
- A NOVEL FLT4 GENE MUTATION AND MR LYMPHANGIOGRAPHY IN A CHINESE FAMILY WITH MILROY DISEASE.
Most Relevant Clinical Trials
- Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein…
- Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Sm…
- NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Rena…
- VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumo…
- A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mu…
